Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$54.87 0.38 (0.70%)
2/9/2010 4:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating GENZ

Add Stock to Watchlist

What the Community Thinks

Total Members

629 Outperforms
30 Underperforms
 

All-Stars

226 Outperforms
12 Underperforms
 

Wall Street

21 Outperforms
0 Underperforms
 

Members bullish on GENZ are also bullish on:

Members bearish on GENZ are also bearish on:

Ticker Tags

Biotechnology (220), S&P 500 (499), Defensive (1457), Large Cap (413), Cambridge (3), Nasdaq 100 (85), Massachusetts (16), Healthcare (711)
Suggest a tag

Genzyme Corp At A Glance

Current Price: $54.87
Last Trade Time: 2/9/2010 4:00 PM
Open: $55.02
Previous Close: $54.49
Daily Range: $54.27 - $55.47
52-Week Range: $47.09 - $73.75
Volume: 2,267,418
Market Cap: $14.56B
P/E Ratio: 30.27
Compare Our Special Broker Offers!

Stock Trends

GENZ VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for GENZ

More Headlines...

Top Bull Pitch

Recs

1

Genzyme Corp (GENZ)

Avatar zzlangerhans (99.64) Submitted: 2/27/09 1:12 AM

Just as Obama enthusiasm for stem cell stocks is senseless, Obama pessimism for pharmaceuticals is overblown. I don't believe his policies will fundamentally change the business model or profitability of mid-to-large cap biotechs, and I see this as another opportunity to green thumb some quality com...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Genzyme Corp (GENZ)

Avatar SatoRey (< 20) Submitted: 8/17/09 6:33 PM

My first concern is around the virus issues in their main manufacturing facility; these contaminations are very difficult to clean up and there are reasonable odds of a recurring event.

Second, and more importantly, I have lost faith in their management. Simle technologies exist to prevent such co...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 62 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (GENZ)

Avatar Newtbuddy (30.05) Submitted: 2/02/10 8:33 PM : Outperform Start Price: $56.25 GENZ Score: -0.03

they'll get over their production issues

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GENZ)

Avatar JuanPeter (50.10) Submitted: 2/02/10 2:43 AM : Underperform Start Price: $54.70 GENZ Score: -2.18

Got a 25% discount last year. We´ll see if Shire's velaglucerase is approved and how GENZ deals with new competitors. Ridiculous P/E, clearly overvalued.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GENZ)

Avatar EDoubleReturns (46.74) Submitted: 1/07/10 12:11 AM : Outperform Start Price: $48.95 GENZ Score: 17.63

The stock is undervalued excluding any further issues with their allston facility. Revenues for the product lines unaffected by the plant closure were all higher in 2009 when compared to 2008. They anticipate having the plant producing at pre-closure levels by the end of the first quarter of 2010. I'm going in...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GENZ)

Avatar reachnvj (82.74) Submitted: 1/06/10 2:15 PM : Outperform Start Price: $48.97 GENZ Score: 17.79

Once all the production issues are behind them, this stock will start soaring. Look for it to go to the $55-60 range by end of 2010.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GENZ)

Avatar Ghastlypc (< 20) Submitted: 1/04/10 12:30 PM : Outperform Start Price: $48.87 GENZ Score: 17.67

over beaten up... unless they can't get their manufacturing issues resolved

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 62 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 21 of 21  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackCitigroup 85.92 12/01/09 Outperform NS $51.62+6.30%-2.06%+8.36
TrackLeerinkSwan 92.83 08/21/09 Outperform NS $53.41+2.73%+5.83%-3.09
TrackPatDorsey 92.89 06/26/09 Outperform 5Y $56.50-2.88%+17.31%-20.19
TrackPiperJaff 85.79 03/27/09 Outperform NS $58.34-5.95%+31.99%-37.94
TrackDeutscheSec 89.68 03/09/09 Outperform NS $54.03+1.55%+60.53%-58.97
TrackBarclaysCap 94.50 03/03/09 Outperform NS $51.79+5.95%+54.78%-48.83
TrackJefferies 82.08 02/12/09 Outperform NS $70.28-21.93%+32.82%-54.75
TrackMorganJos < 20 01/06/09 Outperform NS $68.44-19.83%+16.57%-36.40
TrackBofASec 94.61 08/05/08 Outperform NS $76.81-28.56%-12.22%-16.34
TrackUBS 87.99 07/01/08 Outperform NS $72.33-24.14%-12.61%-11.53
TrackBernstein 87.54 05/14/08 Outperform NS $69.53-21.08%-21.14%+0.06
TrackLazardCapit < 20 04/04/08 Outperform NS $75.09-26.93%-19.30%-7.62
TrackWellsFargo 80.02 10/11/07 Outperform NS $70.00-21.61%-28.42%+6.80
TrackEveillard 93.31 09/30/07 Outperform NS $61.96-11.44%-26.38%+14.93 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 98.91 09/30/07 Outperform NS $61.96-11.44%-26.38%+14.93 Toggle the visibility of 60-Second Pitch and replies
TrackFortisBank 83.59 07/09/07 Outperform NS $61.08-10.17%-26.30%+16.14
TrackLehmanBros 85.06 06/26/07 Outperform NS $64.25-14.60%-24.86%+10.26
TrackMatrix 90.36 03/15/07 Outperform NS $60.40-9.16%-18.11%+8.95
TrackStifel 96.44 01/31/07 Outperform NS $65.33-16.01%-20.21%+4.20
TrackAGEdwards 93.04 08/30/06 Outperform NS $66.46-17.44%-12.66%-4.78
TrackJimCramer < 20 05/25/06 Outperform 3W $58.50-6.21%-10.57%+4.37

Results 1 - 21 of 21  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 812ms